Addex Therapeutics ADXN
NASDAQ ADXN
$2.86 +0.07 (+2.37%)
As of: Nov 10, 2026 · 10:42 AM EST

Addex Therapeutics (ADXN) Divestments (2025)

Updated

Analysis

Addex Therapeutics (ADXN) Divestments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Addex Therapeutics 4.87 Mn -4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,260.23
Sep 30, 2025 75,099.08
API Access

Addex Therapeutics Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=ADXN&period=max&api_key=YOUR_API_KEY